Identification of small molecule compounds active against Staphylococcus aureus and Proteus mirabilis
- PMID: 30409430
- DOI: 10.1016/j.bbrc.2018.10.189
Identification of small molecule compounds active against Staphylococcus aureus and Proteus mirabilis
Abstract
Staphylococcus aureus is a human pathogen rapidly becoming a serious health problem due to ease of acquiring antibiotic resistance. To help identify potential new drug candidates effective against the pathogen, a small focused library was screened for inhibition of bacterial growth against several pathogens, including S. aureus. At least one of the compounds, Compound 10, was capable of blocking bacterial growth of S. aureus in a test tube with IC50 = 140 ± 30 μM. Another inhibitor, Compound 7, was bacteriostatic against S. aureus with IC50 ranging from 33 to 150 μM against 3 different strains. However, only Compound 7 was bactericidal against P. mirabilis as examined by electron microscopy. Human cell line toxicity studies suggested that both compounds had small effect on cell growth at 100 μM concentration as examined by MTT assay. Analysis of compounds' structures showed lack of similarity to any known antibiotics and bacteriostatics, potentially offering the inhibitors as an alternative to existing solutions in controlling bacterial infections for selected pathogens.
Keywords: ATPase; Antibiotic; Bacteriostatic; Electron microscopy; Proteus mirabilis; Staphylococcus aureus.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Biofilm destruction activity of α-tocopherol against Staphylococcus aureus, Proteus mirabilis, and Pseudomonas aeruginosa.FEMS Microbiol Lett. 2025 Jan 10;372:fnaf020. doi: 10.1093/femsle/fnaf020. FEMS Microbiol Lett. 2025. PMID: 39904546 Free PMC article.
-
Comparison of the effects of mecillinam and 6-aminopenicillanic acid on Proteus mirabilis, Escherichia coli, and Staphylococcus aureus.Antimicrob Agents Chemother. 1977 Mar;11(3):541-52. doi: 10.1128/AAC.11.3.541. Antimicrob Agents Chemother. 1977. PMID: 193439 Free PMC article.
-
A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.mSphere. 2018 Oct 31;3(5):e00422-18. doi: 10.1128/mSphere.00422-18. mSphere. 2018. PMID: 30381352 Free PMC article.
-
Anti-biofilm activity of biogenic selenium nanoparticles and selenium dioxide against clinical isolates of Staphylococcus aureus, Pseudomonas aeruginosa, and Proteus mirabilis.J Trace Elem Med Biol. 2015 Jan;29:235-41. doi: 10.1016/j.jtemb.2014.07.020. Epub 2014 Aug 9. J Trace Elem Med Biol. 2015. PMID: 25175509
-
[Prevalence of Proteus mirabilis strains in clinical specimens and evaluation of their resistance to selected antibiotics].Pol Merkur Lekarski. 2004 Nov;17(101):538-40. Pol Merkur Lekarski. 2004. PMID: 15754653 Review. Polish.
Cited by
-
Rapid Analysis for Staphylococcus aureus via Microchip Capillary Electrophoresis.Sensors (Basel). 2021 Feb 13;21(4):1334. doi: 10.3390/s21041334. Sensors (Basel). 2021. PMID: 33668587 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical